Novel, Non–anti-amyloid Shows Early Promise in Alzheimer's - Medscape

Rather than targeting brain amyloid this new investigational drug focuses on an earlier underlying driver of Alzheimer's disease.

Scientists believe they have developed a drug that neutralizes a neurotoxic chemical in the brain that triggers the degenerative process leading to Alzheimer's disease (AD). The drug (NBP14), develo… [+3438 chars]

full article...